Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
February 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
Multiple Myeloma
New Data on Ixazomib Maintenance Support Long-Term Oral Therapy in Patients with Myeloma
Kate Smith
Read More
Multiple Myeloma
Novel Oral Proteasome Inhibitor Oprozomib Shows Promise in Myeloma
Read More
Multiple Myeloma
Weekly Carfilzomib Safe and Effective
Kate Smith
Read More
Lymphoma
Immunotherapy with PD-1 Inhibitors the Newest Breakthrough in Hodgkin Lymphoma
Wayne Kuznar
Read More
Multiple Myeloma
Monoclonal Antibodies Poised to Be “Blockbusters” in Myeloma
Kate Smith
Read More
FDA Approvals
Recent FDA Approvals
Read More
Orphan Drug Expenditures in the United States Expected to Stabilize
Wayne Kuznar
Read More
Economic Value of Survival Gains for MDS Could Exceed $100 Billion
Chase Doyle
Read More
Once Off Patent, Imatinib Will Be the Most Cost-Effective Treatment for Newly Diagnosed CML
Wayne Kuznar
Read More
High Cancer Drug Prices Hurt Patients
Read More
1
2
3
Page 2 of 3
Results 11 - 20 of 26
